BioSpace News Archive

Drug Development

Engineered Microbiome Company Synlogic Doses First Patient in Liver Disease Trial

Synlogic, based in Cambridge, Massachusetts, announced it had dosed its first patient in its Phase Ib/IIa clinical trial of SYNB1020 for hyperammonemia.

April 2, 2018
·
2 min read
·
Mark Terry
Dr. Reddy’s Files NDA for Migraine Treatment

Migraine sufferers could have a new treatment option. India-based Dr. Reddy’s Laboratories and its subsidiary Promius Pharma, LLC filed a NDA with the U.S. FDA for approval of migraine candidate DFN-02.

April 2, 2018
·
2 min read
·
Alex Keown
Business

Compugen and MedImmune Strike Oncology Development Deal Worth up to $200 million

Israel-based drug maker Compugen Ltd. and pharma giant AstraZeneca have teamed up to develop bi-specific and multi-specific immuno-oncology antibody products.

April 2, 2018
·
2 min read
·
Alex Keown
Policy

Novartis Filed Trade Secrets Lawsuit Against Former Executive Who is Now with Biogen

Novartis filed a federal lawsuit against a former executive, Alisha Alaimo. The lawsuit alleged that Alaimo stole confidential files using a flash drive before joining Biogen.

April 2, 2018
·
2 min read
·
Mark Terry
Drug Development

MediciNova Halts Trial Early Following Positive Interim Analysis

Investors in La Jolla, Calif.-based MediciNova are celebrating this morning as company shares are up more than 18 percent following the early completion of a mid-stage non-alcoholic steatohepatitis trial.

April 2, 2018
·
2 min read
·
Alex Keown
New Study Says Research Scientists, Engineers Among Most “Lonely” at Work: Here’s How to Stay Connected When You Work in the Sciences

The Harvard Business Review recently published the results of a workplace survey on loneliness, and research scientists and engineers topped the list of most lonely employees (falling only behind lawyers as the loneliest profession).

April 2, 2018
·
3 min read